|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 26 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-14 |
4 |
B |
$7.41 |
$13,873 |
I/I |
1,871 |
96,941 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-14 |
4 |
B |
$7.41 |
$664,603 |
I/I |
89,632 |
6,470,110 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$150,254 |
I/I |
13,675 |
3,046,857 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$7,944 |
I/I |
723 |
129,053 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$1,033 |
I/I |
94 |
282,043 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$12,097 |
I/I |
1,101 |
131,526 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$380,398 |
I/I |
34,621 |
5,427,653 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-14 |
4 |
B |
$7.41 |
$21,110 |
I/I |
2,847 |
215,646 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-14 |
4 |
B |
$7.41 |
$1,817 |
I/I |
245 |
191,266 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$2,993 |
I/I |
399 |
97,340 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$4,650 |
I/I |
620 |
216,266 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$42,000 |
I/I |
5,600 |
2,437,761 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$353 |
I/I |
47 |
191,313 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$145,005 |
I/I |
19,334 |
6,489,444 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$556,848 |
I/I |
61,872 |
137,470 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$17,400,807 |
I/I |
1,933,423 |
7,326,145 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$5,040,423 |
I/I |
560,047 |
3,814,564 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$359,199 |
I/I |
39,911 |
360,409 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$42,723 |
I/I |
4,747 |
475,754 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-18 |
4 |
B |
$7.15 |
$2,134 |
I/I |
297 |
216,563 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-18 |
4 |
B |
$7.15 |
$165 |
I/I |
23 |
191,336 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-18 |
4 |
B |
$7.15 |
$1,365 |
I/I |
190 |
97,530 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-18 |
4 |
B |
$7.15 |
$19,231 |
I/I |
2,676 |
2,440,437 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-18 |
4 |
B |
$7.15 |
$66,389 |
I/I |
9,238 |
6,498,682 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$18,292 |
I/I |
2,084 |
139,554 |
2.17 |
- |
|
1397 Records found
|
|
Page 26 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|